nach oben

Current Fungal Infection Reports

Erschienen in:

31.01.2023 | COVID-19

Malassezia Folliculitis in the Setting of COVID-19

verfasst von: Alejandro Barrera-Godínez, Grecia Figueroa-Ramos

Erschienen in: Current Fungal Infection Reports | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review recent literature on Malassezia folliculitis and explore its association with COVID-19.

Recent Findings

Reports of Malassezia folliculitis in the setting of COVID-19 are scarce. Shared characteristics between affected individuals include male sex, obesity, intensive care, and administration of systemic antibiotics and systemic steroids. Dexamethasone can potentially stimulate sebum production and therefore lead to Malassezia proliferation. The clinical picture of Malassezia folliculitis accompanying COVID-19 is similar to classic descriptions but tends to spare the face and predominates in occlusion sites.

Summary

Malassezia folliculitis is under-recognized. Fever, sweating, occlusion, immobility, antibiotics, and dexamethasone contribute to COVID-19 patients developing Malassezia folliculitis. Antifungal therapy, together with correcting predisposing factors, is the mainstay of management. Future research should explore the relationship between systemic steroids and other acneiform reactions.

Vijaya Chandra SH, Srinivas R, Dawson TL Jr, Common JE. Cutaneous Malassezia: commensal, pathogen, or protector? Front Cell Infect Microbiol. 2021;10:614446. https://doi.org/10.3389/fcimb.2020.614446.CrossRefPubMedPubMedCentral

• Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;20(10):112. https://doi.org/10.3389/fcimb.2020.00112. A solid recent review about diseases associated with Malassezia and their management.CrossRef

Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106–41. https://doi.org/10.1128/CMR.00021-11.CrossRefPubMedPubMedCentral

• Barrera-Godínez A, Méndez-Flores S, Gatica-Torres M, Rosales-Sotomayor A, Campos-Jiménez KI, Carrillo-Córdova DM, Durand-Muñoz MC, Mena-Hernández GL, Melchor-Mendoza YK, Ruelas-Villavicencio AL, García-Irigoyen A, Acatitla-Acevedo GA, Toussaint-Caire S, Domínguez-Cherit J. Not all that glitters is COVID-19: a case series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection. J Eur Acad Dermatol Venereol. 2021;35(9):1865–1873. https://doi.org/10.1111/jdv.17381. A case series that includes 4 cases of MF confirmed histologically.

• Sandoval C, Rodríguez F, Bonifaz A. Foliculitis por Malassezia en pacientes con COVID-19 portadores de catéter venoso central. Dermatología Revista Mexicana. 2021;65(6):1021–3. A short report describing 3 cases of MF that highlights the role of occlusion.

• Peres FLX, Bonamigo RR, Bottega GB, Staub FL, Cartell AS, Bakos RM. Pityrosporum folliculitis in critically ill COVID-19 patients. J Eur Acad Dermatol Venereol. 2022;36(3):e186–e188. https://doi.org/10.1111/jdv.17842. A short communication that includes 3 cases of MF and explores associated clinical conditions.

• Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, Carrera C, Andreu-Febrer C, Sanz-Beltran J, Riquelme-Mc Loughlin C, Riera-Monroig J, Combalia A, Bosch-Amate X, Morgado-Carrasco D, Pigem R, Toll-Abelló A, Martí-Martí I, Rizo-Potau D, Serra-García L, Alamon-Reig F, Iranzo P, Almuedo-Riera A, Muñoz J, Puig S, Mascaró JM Jr. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med. 2020;9(10):3261. https://doi.org/10.3390/jcm9103261. A large series that includes 2 cases of MF with no accompanying clinical information.

•• Niode NJ, Suling PL, Adji A, Miranda E, Bramono K, Astari L, Ervianti E, Sondakh ORL, Rusmawardiana, Yenny SW, Widasmara D, Lubis FM, Widaty S. Clinico-laboratory findings of Malassezia folliculitis in Indonesia: a multicentre study. Mycoses. 2022;65(10):953–9. https://doi.org/10.1111/myc.13511. The largest published cohort of MF.

Yong AM, Tan SY, Tan CL. An update on pityrosporum folliculitis in Singapore from a single tertiary care dermatological centre. Singapore Med J. 2021;62(10):526–8. https://doi.org/10.11622/smedj.2020068.CrossRefPubMedPubMedCentral

10.

• Tsai YC, Wang JY, Wu YH, Wang YJ. Clinical differences in pediatric and adult Malassezia folliculitis: retrospective analysis of 321 cases over 9 years. J Am Acad Dermatol. 2019;81(1):278–80. https://doi.org/10.1016/j.jaad.2019.03.014. A comparative study focused on risk factors associated with MF, as well as difference between pediatric and adult individuals.CrossRefPubMed

11.

Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol. 2018;78(3):511–4. https://doi.org/10.1016/j.jaad.2017.11.022.CrossRefPubMed

12.

•• Vlachos C, Henning MAS, Gaitanis G, Faergemann J, Saunte DM. Critical synthesis of available data in Malassezia folliculitis and a systematic review of treatments. J Eur Acad Dermatol Venereol. 2020;34(8):1672–83. https://doi.org/10.1111/jdv.16253. A solid, recent review about MF that focuses on treatment options.CrossRefPubMed

13.

Jacinto-Jamora S, Tamesis J, Katigbak ML. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management. J Am Acad Dermatol. 1991;24(5 Pt 1):693–6. https://doi.org/10.1016/0190-9622(91)70104-a.CrossRefPubMed

14.

Tragiannidis A, Bisping G, Koehler G, Groll AH. Minireview: Malassezia infections in immunocompromised patients. Mycoses. 2010;53(3):187–95. https://doi.org/10.1111/j.1439-0507.2009.01814.CrossRefPubMed

15.

Cheikhrouhou F, Guidara R, Masmoudi A, Trabelsi H, Neji S, Sellami H, Makni F, Ayadi A. Molecular identification of Malassezia species in patients with Malassezia folliculitis in Sfax. Tunisia Mycopathologia. 2017;182(5–6):583–9. https://doi.org/10.1007/s11046-017-0113-0.CrossRefPubMed

16.

Durdu M, Güran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis. 2013;76(4):450–7. https://doi.org/10.1016/j.diagmicrobio.2013.04.011.CrossRefPubMed

17.

Akaza N, Akamatsu H, Sasaki Y, Kishi M, Mizutani H, Sano A, Hirokawa K, Nakata S, Nishijima S, Matsunaga K. Malassezia folliculitis is caused by cutaneous resident Malassezia species. Med Mycol. 2009;47(6):618–24. https://doi.org/10.1080/13693780802398026.CrossRefPubMed

18.

Akaza N, Akamatsu H, Takeoka S, Sasaki Y, Mizutani H, Nakata S, Matsunaga K. Malassezia globosa tends to grow actively in summer conditions more than other cutaneous Malassezia species. J Dermatol. 2012;39(7):613–6. https://doi.org/10.1111/j.1346-8138.2011.01477.x.CrossRefPubMed

19.

Park HR, Oh JH, Lee YJ, Park SH, Lee YW, Lee S, Kang H, Kim JE. Inflammasome-mediated Inflammation by Malassezia in human keratinocytes: a comparative analysis with different strains. Mycoses. 2021;64(3):292–9. https://doi.org/10.1111/myc.13214.CrossRefPubMed

20.

Jakhar D, Bhatia V, Gupta RK, Kaur I. Dermoscopy as an auxiliary tool in the assessment of Malassezia folliculitis: an observational study. Actas Dermosifiliogr. 2022;113(1):T78–81. https://doi.org/10.1016/j.ad.2020.05.012.CrossRefPubMed

21.

Tsai YC, Wang JY, Wu YH, Wang YJ. Atypical clinical presentations of Malassezia folliculitis: a retrospective analysis of 94 biopsy-proven cases. Int J Dermatol. 2018;57(3):e19–20. https://doi.org/10.1111/ijd.13880.CrossRefPubMed

22.

An MK, Hong EH, Cho EB, Park EJ, Kim KH, Kim KJ. Clinicopathological differentiation between Pityrosporum folliculitis and acneiform eruption. J Dermatol. 2019;46(11):978–84. https://doi.org/10.1111/1346-8138.15070.CrossRefPubMed

23.

Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int J Dermatol. 1998;37(10):772–7. https://doi.org/10.1046/j.1365-4362.1998.00229.x.CrossRefPubMed

24.

Pürnak S, Durdu M, Tekindal MA, Güleç AT, Seçkin D. The prevalence of Malassezia folliculitis in patients with papulopustular/comedonal acne, and their response to antifungal treatment. Skinmed. 2018;16(2):99–104.PubMed

25.

Sei Y. Malassezia infections. Med Mycol J. 2012;53(1):7–11. https://doi.org/10.3314/mmj.53.7.CrossRefPubMed

26.

• Tu WT, Chin SY, Chou CL, Hsu CY, Chen YT, Liu D, Lee WR, Shih YH. Utility of Gram staining for diagnosis of Malassezia folliculitis. J Dermatol. 2018;45(2):228–31. https://doi.org/10.1111/1346-8138.14120. A study that highlights the usefulness of Gram staining as a tool in diagnosing the cause of folliculitis.CrossRefPubMed

27.

Jakhar D, Kaur I, Chaudhary R. Dermoscopy of pityrosporum folliculitis. J Am Acad Dermatol. 2019;80(2):e43–4. https://doi.org/10.1016/j.jaad.2018.08.057.CrossRefPubMed

28.

Andersen AJB, Fuchs C, Ardigo M, Haedersdal M, Mogensen M. In vivo characterization of pustules in Malassezia folliculitis by reflectance confocal microscopy and optical coherence tomography. A case series study. Skin Res Technol. 2018;24(4):535–41. https://doi.org/10.1111/srt.12463.CrossRefPubMed

29.

Chaitidis N, Festas C, Aritzi I, Kyriazopoulou M. Oral treatment with/without topical treatment vs topical treatment alone in Malassezia folliculitis patients: a systematic review and meta-analysis. Dermatol Ther. 2020;33(3):e13460. https://doi.org/10.1111/dth.13460.CrossRefPubMed

30.

Lee SE, Kim JM, Jeong MK, Zouboulis CC, Lee SH. 11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes. Br J Dermatol. 2013;168(1):47–55. https://doi.org/10.1111/bjd.12009.CrossRefPubMed

Titel: Malassezia Folliculitis in the Setting of COVID-19
verfasst von: Alejandro Barrera-Godínez
Grecia Figueroa-Ramos
Publikationsdatum: 31.01.2023
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current Fungal Infection Reports / Ausgabe 1/2023
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-023-00450-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Malassezia Folliculitis in the Setting of COVID-19

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Candidiasis and Other Emerging Yeasts

The Impact of Corticosteroids on the Outcome of Fungal Disease: a Systematic Review and Meta-analysis

Management of Fungal Osteoarticular Infections

A Critical Review of Diagnostic Methods for Disseminated Histoplasmosis with Special Focus on Resource-Limited Settings

Coccidioidomycosis in Pregnancy: an Update on Contributions to the Literature in the Past 5 Years

Diagnostic Challenges of Coccidioidomycosis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin